Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| First combined analysis of SMN1, SMN2, and NAIP copy numbers in Moroccan SMA patients and their correlation with disease severity. | Mol Genet Metab Rep | 2026 | 41773285 | PubTator, text mining | PubMed |
Comparison of Nusinersen Monotherapy Versus Combination Therapy With Nusinersen and Onasemnogene Abeparvovec in Spinal Muscular Atrophy Type 1 Patients With Two SMN2 Copies: A Multicenter Study From Türkiye. | Muscle Nerve | 2026 | 41757676 | PubTator, text mining | PubMed |
| Comparative Characterization of a Proposed Generic Nusinersen: Identity of the Oligonucleotide Structure and Equivalence in SMN2 Splicing Activity. | Pharmaceutics | 2026 | 41754920 | PubTator, text mining | PubMed |
| Adult Survival in SMA Type 1: A 23-Year Journey With Home Ventilation and Multidisciplinary Support. | Clin Case Rep | 2026 | 41737973 | PubTator, text mining | PubMed |
| Unlocking the potential of computational phenotypic drug discovery: methods, challenges, and future directions. | NPJ Syst Biol Appl | 2026 | 41735310 | PubTator, text mining | PubMed |
| RNA-based discovery and correction of splicing defects caused by POLR3A missense mutations. | Mol Ther Nucleic Acids | 2026 | 41732205 | PubTator, text mining | PubMed |
| Neonatal Genetic Screening Results for Spinal Muscular Atrophy in Romania: Insights from a 3-Years Pilot Program. | Int J Neonatal Screen | 2026 | 41718420 | PubTator, text mining | PubMed |
| Disparities in Spinal Muscular Atrophy-Related Mortality in the United States, 2018-2023. | NeuroSci | 2026 | 41718151 | PubTator, text mining | PubMed |
Immediate and Sustained Effects of Intensive Equine-Assisted Physiotherapy Based on Neuroproprioceptive "Facilitation and Inhibition" on Psychomotor Development, Clinical Functions, Quality of Life, and Molecular Biological Indicators in Children With Spinal Muscular Atrophy: Protocol for a Crossover Randomized Controlled Trial. | JMIR Res Protoc | 2026 | 41712782 | PubTator, text mining | PubMed |
| Author Correction: Genotyping sequence-resolved copy number variation using pangenomes reveals paralog-specific global diversity and expression divergence of duplicated genes. | Nat Genet | 2026 | 41699139 | PubTator, text mining | PubMed |
| Spinal muscular atrophy among US Hutterites: Phenotype variability in the setting of conserved ancestral haplotype and 4 SMN2 copies. | Genet Med | 2026 | 41691542 | PubTator, text mining | PubMed |
| Clinical diagnosis and genetic analysis of a rare case of Duchenne muscular dystrophy and spinal muscular atrophy. | Mol Cytogenet | 2026 | 41691287 | PubTator, text mining | PubMed |
| SMN1 variants identified by false-positive SMA newborn screening tests: Therapeutic hurdles and functional and epidemiological solutions. | Am J Hum Genet | 2026 | 41687605 | PubTator, text mining | PubMed |
| Semi-automated genomic newborn screening highlights complexities in reporting. | NPJ Genom Med | 2026 | 41667506 | PubTator, text mining | PubMed |
| Examination of the Peripheral Nervous System in Children With Spinal Muscular Atrophy: A High-Resolution Ultrasonographic Study. | Brain Behav | 2026 | 41645345 | PubTator, text mining | PubMed |
| Design and evaluation of semantically-valid negative samples integration techniques for scalable semi-automated drug repurposing prediction pipelines in rare disease research. | BMC Bioinformatics | 2026 | 41639620 | PubTator, text mining | PubMed |
| RNA-Based Therapies for Inherited Metabolic Disorders. | J Inherit Metab Dis | 2026 | 41621836 | PubTator, text mining | PubMed |
| Loss of ambulation in SMA III at the time of disease-modifying treatments: an international study. | J Neurol Neurosurg Psychiatry | 2026 | 41617535 | PubTator, text mining | PubMed |
| Beyond motor function: cognitive and language impairments in spinal muscular atrophy children treated with modern therapies. | Neuromuscul Disord | 2026 | 41616662 | PubTator, text mining | PubMed |
| Effectiveness of Risdiplam Treatment in Adult Patients With Spinal Muscular Atrophy Type IIb-III. | Rev Neurol | 2026 | 41609131 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=5